SCHEMBL9920939

SCHEMBL9920939

Cc1ccc(-c2ccc3ccc4c(-c5ccc(C)c6ccccc56)cc(-n5c6ccccc6c6ccccc65)c5ccc2c3c45)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 5/20 0.35
KDM4E B2RXH2 3/20 0.32
MAPT P10636 3/20 0.32
FYN P06241 2/20 0.31
ACHE P22303 2/20 0.31
AHR P35869 2/20 0.31
ERBB2 P04626 1/20 0.31
MAOA P21397 1/20 0.31
ATM Q13315 1/20 0.31
LCK P06239 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
SLC6A2 P23975 1/20 0.31
PABPC1 P11940 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9920941 0.85 CYP1A2 (0.38) ALDH1A1L3MBTL1TSHRHPGDHSD17B10
SCHEMBL2083628 0.82 ALDH1A1 (0.52) ALDH1A1L3MBTL1TSHRCYP3A4HPGD
SCHEMBL9920749 0.82 MAPT (0.35) ALDH1A1L3MBTL1TSHRCYP3A4HPGD
SCHEMBL9920942 0.82 MAPT (0.35) ALDH1A1L3MBTL1TSHRCYP3A4HPGD
SCHEMBL9920944 0.81 CYP1A2 (0.37) ALDH1A1L3MBTL1TSHRHPGDHSD17B10
SCHEMBL9920742 0.81 ALDH1A1 (0.52) ALDH1A1L3MBTL1TSHRCYP3A4HPGD
SCHEMBL9920981 0.81 HSD17B10 (0.37) ALDH1A1L3MBTL1HPGDHSD17B10TDP1
SCHEMBL9920744 0.81 HSD17B10 (0.37) ALDH1A1L3MBTL1HPGDHSD17B10TDP1
SCHEMBL9921046 0.79 MAPT (0.35) ALDH1A1L3MBTL1TSHRCYP3A4HPGD
SCHEMBL4129543 0.79 ALDH1A1 (0.59) ALDH1A1L3MBTL1TSHRCYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463352-B1 Light emitting device material and light emitting device TORAY INDUSTRIES (JP) 2018-05-02 EP disclosed
EP-1942171-B1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES (JP) 2018-04-18 EP disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-20140061629-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2014-03-06 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
US-8502201-B2 Light-emitting element TORAY INDUSTRIES, INC. (JP) 2013-08-06 US disclosed
EP-2463352-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
EP-2463351-A2 Light emitting device material and light emitting device Toray Industries, Inc. (JP) 2012-06-13 EP disclosed
US-20110121268-A1 LIGHT-EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2011-05-26 US disclosed
US-20110121268-A1 LIGHT-EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2011-05-26 US disclosed
US-20090096356-A1 Light-emitting device material and light-emitting device TORAY INDUSTRIES, INC. (JP) 2009-04-16 US disclosed
EP-1942171-A1 LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2008-07-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090096356-A1 Light-emitting device material and light-emitting device PRMT9, CCNL2, MRPL9 ALDH1A1 1929/4885L3MBTL1 283/4885TSHR 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.